Evaluation of potential tumor markers that may predict neoadjuvant treatment efficiency in rectal cancer
Open Access
- 5 January 2021
- journal article
- research article
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 46 (4) , 445-454
Abstract
Objectives: The recurrence of rectal cancer or its resistance to neoadjuvant treatment develops due to the adaptation to hypoxia, apoptosis or autophagy. Survivin, one of the inhibitors of apoptosis; Beclin 1, which is a positive regulator in the autophagy pathway; and hypoxia-inducible factor-1α (HIF-1α) and carbonic anhydrase-9 (CA9), which are associated with tumor tissue hypoxia, may be related to resistance to treatment. Our aim was to evaluate the potential tumor markers that may help to monitor the response to neoadjuvant treatment in locally advanced rectal cancer (RC). Methods: Twenty-five patients with locally advanced RC were included in the study. Gene expression and protein levels of Beclin 1, Survivin, HIF-1α, and CA9 were analyzed in fresh tissue specimens and blood samples. The relationships of these markers to tumor staging and regression grade were evaluated. Results: Higher blood CA9 gene expression levels and lower blood HIF-1α protein levels were found in the response group according to tumor regression grade. After neoadjuvant treatment, tissue Beclin 1 and blood Survivin gene expressions and tissue CA9, blood Beclin 1 and blood HIF-1α protein levels decreased significantly. Conclusion: Beclin 1, Survivin, HIF-1α ve CA9 may help to predict the effects of the applied treatment approach.Keywords
Funding Information
- Scientific and Technological Research Council of Turkey (116S225)
This publication has 35 references indexed in Scilit:
- Prognostic and Clinicopathological Significance of Survivin in Colorectal Cancer: A Meta-AnalysisPLOS ONE, 2013
- Hypoxia and cytokines regulate carbonic anhydrase 9 expression in hepatocellular carcinoma cellsin vitroWorld Journal of Clinical Oncology, 2012
- Depletion of tissue factor suppresses hepatic metastasis and tumor growth in colorectal cancer via the downregulation of MMPs and the induction of autophagy and apoptosisCancer Biology & Therapy, 2011
- The regulation of autophagy – unanswered questionsJournal of Cell Science, 2011
- Interaction of Beclin 1 with survivin regulates sensitivity of human glioma cells to TRAIL‐induced apoptosisFEBS Letters, 2010
- Gene Expression Profiles of Epidermal Growth Factor Receptor, Vascular Endothelial Growth Factor and Hypoxia-inducible Factor-1 with Special Reference to Local Responsiveness to Neoadjuvant Chemoradiotherapy and Disease Recurrence After Rectal Cancer SurgeryClinical Oncology, 2010
- Expression of carbonic anhydrase IX suggests poor outcome in rectal cancerBritish Journal of Cancer, 2009
- Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesisCancer Cell, 2006
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001